|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$128,455,406 |
|
|
Indirect Value
|
$40,265,984 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$168,721,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 31 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KPRX |
Kiora Pharmaceuticals |
10% Owner |
|
2018-04-19 |
4 |
B |
$0.48 |
$599,299 |
D/D |
1,256,920 |
15,750,674 |
2.45 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2018-06-28 |
4 |
B |
$1.19 |
$1,538,981 |
D/D |
1,276,591 |
4,360,500 |
2.45 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-04-28 |
4 |
S |
$3.38 |
$4,367,197 |
D/D |
(1,292,070) |
23,907,930 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-11 |
4 |
S |
$2.79 |
$3,627,000 |
D/D |
(1,300,000) |
14,400,000 |
0 |
% |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2020-12-11 |
4 |
B |
$6.00 |
$8,000,004 |
D/D |
1,333,334 |
1,333,334 |
2.39 |
% |
|
CYTH |
Cyclo Therapeutics, Inc |
10% Owner |
|
2020-09-08 |
4 |
S |
$0.16 |
$213,997 |
D/D |
(1,337,482) |
17,356,826 |
0 |
% |
|
TTPH |
Tetraphase Pharmaceutical... |
Director |
|
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,419,507) |
0 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2020-03-10 |
4 |
D |
$1.30 |
$1,933,931 |
D/D |
(1,487,639) |
18,119,637 |
0 |
- |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2021-01-06 |
4 |
B |
$5.23 |
$8,000,003 |
D/D |
1,531,101 |
3,346,601 |
3.92 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-12 |
4 |
S |
$3.02 |
$4,774,850 |
D/D |
(1,581,076) |
12,818,924 |
0 |
% |
|
VXRT |
Vaxart Inc |
10% Owner |
|
2019-09-30 |
4 |
B |
$0.33 |
$528,124 |
D/D |
1,600,376 |
24,000,000 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-06-09 |
4 |
B |
$2.50 |
$4,384,200 |
D/D |
1,753,680 |
29,914,285 |
3.92 |
% |
|
KPRX |
Kiora Pharmaceuticals |
10% Owner |
|
2018-04-17 |
4 |
B |
$0.44 |
$837,670 |
D/D |
1,895,610 |
13,712,500 |
2.45 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-17 |
4 |
B |
$2.05 |
$3,999,999 |
D/D |
1,951,219 |
28,160,605 |
3.92 |
% |
|
FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
|
2019-01-10 |
4 |
S |
$0.88 |
$1,930,707 |
D/D |
(2,190,500) |
2,170,000 |
0 |
- |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2021-07-27 |
4 |
S |
$3.80 |
$12,113,647 |
I/I |
(2,377,695) |
1,821,406 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-01-08 |
4 |
B |
$2.60 |
$6,500,000 |
D/D |
2,500,000 |
32,634,285 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2023-06-26 |
4 |
S |
$0.61 |
$1,682,010 |
I/I |
(2,746,138) |
1,668,862 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2019-10-30 |
4 |
OE |
$0.88 |
$2,421,010 |
D/D |
2,751,148 |
7,871,212 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000,000 |
28,683,233 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2019-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,120,064 |
5,120,064 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,455,129) |
26,209,386 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-06-29 |
4 |
OE |
$1.10 |
$4,500,000 |
D/D |
4,090,909 |
9,530,909 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-04-30 |
4 |
S |
$2.96 |
$13,125,516 |
D/D |
(4,434,296) |
18,600,000 |
0 |
% |
|
VXRT |
Vaxart Inc |
10% Owner |
|
2019-09-26 |
4 |
B |
$0.28 |
$1,332,888 |
D/D |
4,760,314 |
21,426,981 |
2.45 |
- |
|
790 Records found
|
|
Page 31 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|